US FDA Convinced: Cosmetic Adverse Event Reports Aren’t Telling Whole Story
Linda Katz, director of the FDA’s cosmetics office, says to “stay tuned” for federal legislative developments in 2022, maintaining her position that voluntary adverse-event reporting paints an incomplete picture of consumers’ experience with cosmetic products across the US.
You may also be interested in...
Greenberg Traurig and Hogan Lovells attorneys provide first breakdowns of the game-changing Modernization of Cosmetic Regulations Act, including the potential for new lawsuits and plaintiff tactics.
The International Cooperation on Cosmetics Regulations continues efforts to minimize barriers to international trade through regulatory convergence, while also taking steps to educate consumers on cosmetics safety issues that may be widely misunderstood. Personal Care Products Council leadership discusses developments from the regulator group’s 15th annual meeting in June.
Beautycounter and Burt’s Bees are among the most vocal companies pushing for modernization of US cosmetics regulations via the proposed Personal Care Products Safety Act, which would require the FDA to establish a “natural” definition for use in product labeling.